Pharmacogenomics · 2012 · 46 citations · 54 references
Veterinary MedicinePharmacokineticsPharmacologyPharmacogeneticsPharmacogenomicsPharmacovigilanceClinical Implementation Of PharmacogeneticsDrug Metabolism GeneticsGermline Pharmacogenetic VariationPharmacogenetic TestingPharmacogenomic TestingPopulation PharmacogeneticsAdverse Drug Reaction GeneticsPharmacogenetic Studies
The safety and efficacy of candidate compounds are critical factors during the development of drugs, and most drugs have been withdrawn from the market owing to severe adverse reactions. Individuals/populations with different genetic backgrounds may show significant differences in drug metabolism and efficacy, which can sometimes manifest as severe adverse drug reactions. With an emphasis on the mechanisms underlying abnormal drug effects caused by genetic mutations, pharmacogenetic studies may enhance the safety and effectiveness of drug use, provide more comprehensive delineations of the scope of usage, and change the fates of drugs withdrawn from the market.
54
Spectrum of Mutations in Long-QT Syndrome Genes
Igor Splawski, Jiaxiang Shen, Katherine W. Timothy et al. · Circulation · 2000 · 1.2K citations · Full text
Life Sciences, Cardiology, Genetics +15
Appetite-Suppressant Drugs and the Risk of Primary Pulmonary Hypertension
Lucien Abenhaim, Yola Moride, François Brenot et al. · New England Journal of Medicine · 1996 · 1.2K citations · Full text
Allelic Variants in Long-QT Disease Genes in Patients With Drug-Associated Torsades de Pointes
Ping Yang, Hideaki Kanki, Benoît Drolet et al. · Circulation · 2002 · 552 citations